Omnix Medical

We had an incredible experience at ID Week in Los Angeles! Engaging with brilliant professionals and learning from lectures and KOLs was truly inspiring. We showcased our cutting-edge technology that’s transforming infection treatment and saving lives, while exchanging valuable insights with colleagues from around the world. It was a fantastic event. See you next year at #IDWeek2025 in Atlanta! Niv Bachnoff Moshik Cohen-Kutner Tamar Shachar (Antebi) Omnix Medical

Melissa Murray regularly ran 10 km a day—until a serious infection caused her to nearly lose a leg. She had an invasive Group A strep (iGAS) bacterial infection that could not be treated with standard antibiotics and suddenly needed round-the-clock care. Read more via CBC https://t.co/U3hQfjWsix #AMR

The Omnix Team is heading to #IDWeek2024 in Los Angeles! Dr. Moshik Cohen-Kutner, CEO, Dr. Niv Bachnoff, CSO, and Ms. Tamar Shachar (Antebi), BPharm MSc, Head of Formulation will be presenting the latest results from our Phase I clinical trial of OMN6.   Come speak with us. We look forward to seeing you there.   Poster Presentation 🗓 Thurs, Oct 17  ⏰ 12:15 PM - 1:30 PM   📍 Hall J & K #amr #antimicrobialresistance #drugdiscovery

#Antimicrobial_Peptides_Market Size Surge Driven by Rising Infections and Advanced Therapeutics https://lnkd.in/deDCzd_m Armata Pharmaceuticals, Inc. ContraFect Corp AbGenics Lifesciences Maxwell Biosciences Hycult Biotech Omnix Medical ImQuest BioSciences Evotec Anti-Infectives Norbite Enhalor Computer-Aided Therapeutic Discovery and Design Platform Madam Therapeutics KFUPM-Saudi Arabia RELIANCE HE Project AgriBiotix AS AJK Biopharmaceutical IMEnz Bioengineering BV ChainPeptides Oy QUANTEC Limited Genvor Inc. Peptomer Therapeutics Symbiose Biomaterials Kinnear Pharmaceuticals DermaGen AB phiphar.com International AMP Network MD.USE Innovative Solutions S.L. Amphoraxe Life Sciences Inc. BioGenies Biovit Co., Ltd P4Microbiome Pepthera Laboratories Pvt. Ltd. Bombi Biomics BV The FORMAMP Project MaxImmun Promecens Entosystems Private Limited Cancer and Infectious Diseases Nomora Ltd. RADOV Mucin Beauty #Antimicrobial_Peptides_Market #health #healthcare #biotechnology #pharmacutical #growth #size #share #forecast

Omnix Medical is looking forward to attending the 2024 ESCMID/ASM joint Conference on drug development in Porto, Portugal, 17–20 September. We hope to see you there. Let’s tackle the growing threat of antimicrobial resistance. #AMR #ASMESCMID #ASM #ESCMID 

Join us at #MHSRS2024 as Omnix Medical presents groundbreaking solutions to combat AMR! Our lead compound, OMN6, is a revolutionary antimicrobial peptide inspired by insect immune systems, offering a fast-acting, potent, and safe treatment for life-threatening infections. With our unique technology, we're on the frontlines of the war against drug-resistant bacteria. 🌍💉 If you plan to attend the 2024 Military Health System Research Symposium in Kissimmee, Florida next week, join us for this important breakout session: Strategies for Mitigating the Development of Post-traumatic Wound Infections with Multi-drug Resistant Organisms across the Continuum of Care 🗓️ Wednesday 28 Aug 🕐 1300-1500 #Superbugs #AMR #InnovationInHealth

New breeds of drug-resistant bacteria are proliferating in war-torn parts of the globe — and spreading from the battlefield to hospitals and across borders. https://lnkd.in/eknA9-gP

Hospital-Acquired Infection Rates Remain High Post-Pandemic https://lnkd.in/gaW4Sdhy   According to recent findings from the US National Institute of Allergy and Infectious Diseases, hospital-acquired infections associated with #AMR continue to increase even as we move past the pandemic, underscoring the urgent need for innovative treatments and interventions.   At Omnix Medical, we are committed to addressing this critical issue. Our systemic IV treatment, designated as a Qualified Infectious Disease Product (QIDP) by the FDA, is designed to combat severe and life-threatening infections, including:   -Hospital/Ventilator Associated Bacterial Pneumoniae (HABP/VABP) -Blood Stream Infections (BSI) -Complicated Urinary Tract Infections (cUTI)   Our mission is to provide effective solutions that reduce the burden of these infections on patients and healthcare systems. Together, we can help reduce the prevalence of hospital-acquired infections and improve patient outcomes.   https://lnkd.in/gaW4Sdhy   #Healthcare #InfectionPrevention #PatientSafety

Omnix Medical is proud to announce our recent recognition by the Israel Innovation Authority (IIA), awarding us a prestigious grant to further our mission of developing groundbreaking solutions to address antimicrobial resistance. The support of the IIA for Omnix’s first-of-its-kind drug is set to revolutionize the anti-infective landscape and provide crucial advancements in lifesaving treatments. #amr #antimicrobialresistance #pharmainnovation #drugdiscovery

We look forward to seeing you in one week at the ESCMID Global 2024 Conference in Barcelona. Omnix Medical is pleased to be presenting the poster “A Phase I first-in-human study in healthy volunteers with intravenously administered OMN6, a novel antimicrobial peptide targeting Acinetobacter baumannii”. Stop by the poster to discuss this consequential technology with Niv Bachnoff (CSO) and Moshik Cohen-Kutner (CEO) #ESCMIDGlobal2024